32 related articles for article (PubMed ID: 2614988)
1. [A case of mixed connective tissue disease developed into overlap syndrome of progressive systemic sclerosis, systemic lupus erythematosus, polymyositis and Sjögren's syndrome].
Akiyama Y; Suzuki T; Tanaka M; Kobayashi K; Kagiri T; Ishibashi T; Kitagawa H; Imai F; Hara K; Doi Y
Arerugi; 1990 Jun; 39(6):542-7. PubMed ID: 2222196
[TBL] [Abstract][Full Text] [Related]
2. Nailfold capillary abnormalities in patients with Sjögren's syndrome and systemic lupus erythematosus.
Ohtsuka T
Br J Dermatol; 1997 Jan; 136(1):94-6. PubMed ID: 9039302
[TBL] [Abstract][Full Text] [Related]
3. Cyclosporin a therapy in patients with primary Sjögren's syndrome: results at one year.
Drosos AA; Skopouli FN; Galanopoulou VK; Kitridou RC; Moutsopoulos HM
Scand J Rheumatol Suppl; 1986; 61():246-9. PubMed ID: 3296152
[TBL] [Abstract][Full Text] [Related]
4. [Clinical analysis of anti-cardiolipin antibody positive patients with systemic lupus erythematosus].
Otoyama K; Katayama I; Nishioka K; Nishiyama S
Nihon Hifuka Gakkai Zasshi; 1989 Apr; 99(5):537-41. PubMed ID: 2585769
[TBL] [Abstract][Full Text] [Related]
5. Expression of CD5 and CD23 on B cells of patients with rheumatoid arthritis, systemic lupus erythematosus and Sjögren's syndrome. Relationship with disease activity and treatment.
Ebo D; DeClerck LS; Bridts CH; Stevens WJ
In Vivo; 1994; 8(4):577-80. PubMed ID: 7534494
[TBL] [Abstract][Full Text] [Related]
6. [A case of overlap syndrome of PSS, SLE and Sjögren syndrome treated by cyclosporin A: an improvement of sclerosis of the skin].
Kume A; Ueda K; Sano S; Funai T; Kobayashi Y; Hashimoto K; Yoshikawa K
Nihon Hifuka Gakkai Zasshi; 1989 Oct; 99(11):1191-6. PubMed ID: 2614988
[TBL] [Abstract][Full Text] [Related]
7. A critical review of the effect of levamisole in rheumatic diseases other than rheumatoid arthritis.
Rosenthal M
J Rheumatol Suppl; 1978; 4():97-100. PubMed ID: 366146
[TBL] [Abstract][Full Text] [Related]
8. Inclusion body myositis in connective tissue disorders: case report and review of the literature.
Derk CT; Vivino FB; Kenyon L; Mandel S
Clin Rheumatol; 2003 Oct; 22(4-5):324-8. PubMed ID: 14576992
[TBL] [Abstract][Full Text] [Related]
9. Autoimmune rheumatic diseases in women.
Schuna AA
J Am Pharm Assoc (Wash); 2002; 42(4):612-23; quiz 623-4. PubMed ID: 12150360
[TBL] [Abstract][Full Text] [Related]
10. The risk of lymphoma development in autoimmune diseases: a meta-analysis.
Zintzaras E; Voulgarelis M; Moutsopoulos HM
Arch Intern Med; 2005 Nov; 165(20):2337-44. PubMed ID: 16287762
[TBL] [Abstract][Full Text] [Related]
11. Experimental and induced animal models of systemic lupus erythematosus and Sjögren's syndrome.
Shoenfeld Y
Curr Opin Rheumatol; 1989 Oct; 1(3):360-8. PubMed ID: 2701690
[No Abstract] [Full Text] [Related]
12. B cell depletion therapy in rheumatic disease.
Edwards JC; Cambridge G; Leandro MJ
Best Pract Res Clin Rheumatol; 2006 Oct; 20(5):915-28. PubMed ID: 16980214
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
